September 2025
The global continuous blood pressure monitoring devices market is on an upward trajectory, poised to generate substantial revenue growth, potentially climbing into the hundreds of millions over the forecast years from 2025 to 2034. This surge is attributed to evolving consumer preferences and technological advancements reshaping the industry.
The continuous blood pressure monitoring devices market is primarily driven by the burgeoning medical device sector and the increasing awareness of continuous monitoring of blood pressure. Ongoing efforts are made to develop novel blood pressure monitoring devices with enhanced accuracy and precision. Prominent players collaborate to access advanced technologies and deliver their products to a large patient population. By leveraging artificial intelligence (AI), devices can send real-time data to healthcare professionals. Advances in wearable devices offer significant potential for market growth in the future.
The continuous blood pressure monitoring devices market refers to the development, manufacturing, and distribution of these devices. Continuous blood pressure monitoring devices can record and monitor blood pressure over 24 hours, even while sleeping. They can detect blood pressure patterns, such as white coat hypertension, sustained hypertension, masked hypertension, and nocturnal hypertension. They can help detect blood pressure without the need for any skilled professional.
Government Support: Government organizations collaborate with regulatory bodies to manage and control chronic disorders in their respective nations.
Increasing Investment: Medical device startups raise funding to develop and launch innovative blood pressure monitoring devices, fostering the continuous blood pressure monitoring devices market.
AI revolutionizes the continuous blood pressure monitoring devices market by leading to the development of automated devices. AI can provide real-time data to healthcare professionals, enabling them to make proactive clinical decisions. AI and machine learning (ML) algorithms can analyze vast amounts of data and suggest minor fluctuations in patients’ blood pressure. They enhance the accuracy, precision, and reproducibility of blood pressure monitoring. They also help providers in analyzing the results generated from the devices, allowing them to provide personalized treatment and care.
Rising Prevalence of Cardiovascular Diseases
The major growth factor for the continuous blood pressure monitoring devices market is the rising prevalence of cardiovascular diseases. Cardiovascular diseases, such as heart failure, stroke, peripheral artery disease, and hypertension, are the major causes of disability and death globally. Sedentary lifestyles, modifiable behavioral risk factors, and poor dietary choices are the major risk factors of cardiovascular diseases. The World Health Organization (WHO) reported that hypertension affects more than 294 million people across the WHO South-East Asia Region.
High Cost
Continuous blood pressure monitoring devices are comparatively more expensive than regular blood pressure devices. The average cost of these devices ranges from $190 to $2300. This limits the affordability of several patients and healthcare professionals from low- and middle-income countries, restricting market growth.
Advances in Wearable Technology
The future of the continuous blood pressure monitoring devices market is promising, driven by advances in wearable technology. Innovative wearable devices are developed to detect cardiac output and pulse waveform features using dual photoplethysmography (PPG) sensors. Changing consumer preferences from cuff-based devices potentiates the demand for portable wearable devices. The cuff has to be adjusted to the arm size, leading to low patient compliance. Wearable devices also measure blood pressure through non-invasive methods in real-time.
By device type, the wrist-based monitors segment held a dominant presence in the continuous blood pressure monitoring devices market in 2024. This is due to the ease of use and enhanced convenience. Wrist-based monitors are devices that are tied to the wrist. They contain a cuff that attaches to a digital display screen that shows blood pressure readings. They help patients to monitor blood pressure through a person’s radial artery while conducting daily routine tasks.
By device type, the wearable devices segment is expected to grow at the fastest CAGR in the market during the forecast period. Wearable devices offer continuous, real-time blood pressure readings, facilitating the early detection and prevention of hypertension. They are more affordable and accurate compared to wrist monitors. Smartwatches are equipped with blood pressure tracking, inflatable cuffs, and patch- and skin-compatible sensors. Apart from blood pressure, wearable devices can also measure vital signs, such as sleep and pulse rate.
By technology, the bioimpedance segment held the largest revenue share of the continuous blood pressure monitoring devices market in 2024. This segment dominated because bioimpedance (BI) measurement is a promising approach for detecting fluctuations in blood pressure. It reflects minor changes in blood pressure through the change in arterial cross-sectional area. BI enables healthcare professionals to transform next-generation personalized healthcare. AI algorithms are used to extract blood pressure features from the measured BI signals.
By technology, the photoplethysmography (PPG) segment is expected to grow with the highest CAGR in the market during the studied years. PPG is a non-invasive optical technique that works by measuring volumetric fluctuations in blood circulation. The demand for using PPG technology is increasing due to its potential to enable beat-to-beat blood pressure monitoring. PPG also offers a more detailed and responsive hypertension management with the help of contact and contactless sensors.
By application, the hypertension management segment contributed the biggest revenue share of the continuous blood pressure monitoring devices market in 2024. The segmental growth is attributed to the rising prevalence of hypertension and the growing geriatric population. Older people are more prone to developing hypertension due to sedentary lifestyles, excessive salt intake, and genetic factors. Healthcare professionals encourage patients to measure blood pressure at regular intervals, potentiating the demand for continuous blood pressure monitoring. This enables patients to diagnose high blood pressure early, so it may be treated before it leads to serious complications.
By application, the neurological disorders segment is expected to expand rapidly in the market in the coming years. Scientists have linked hypertension with neurological diseases as a risk factor for target organ damage, including the brain. Hypertension is associated with neuroinflammation, disruption of cerebral microcirculation’s structural and functional integrity, and disruption of the blood-brain barrier integrity. This necessitates patients to continuously monitor their blood pressure.
By end-user, the hospitals & clinics segment led the continuous blood pressure monitoring devices market in 2024. This is due to the availability of favorable infrastructure and suitable capital investment in hospitals & clinics. Healthcare professionals can adopt advanced technological products for monitoring blood pressure. Hospitals & clinics have skilled professionals from multiple departments, providing multidisciplinary expertise to patients. Patients receive favorable reimbursements from health insurance companies, making hospitals & clinics a suitable choice.
By end-user, the homecare settings segment is expected to witness the fastest growth in the market over the forecast period. The increasing geriatric population and the growing number of employed people augment the segment’s growth. Continuous blood pressure monitoring devices are portable and affordable, which increases accessibility to these devices. They eliminate the need to visit a healthcare organization, saving time and costs. The growing demand for remote monitoring and telemedicine also propels the segment’s growth.
North America dominated the global continuous blood pressure monitoring devices market in 2024. The availability of state-of-the-art research and development facilities, the presence of key players, and favorable regulatory policies are the major growth factors for the market in North America. Favorable government support and increasing collaborations among key players boost the market. People are aware of advanced technological products for continuously monitoring blood pressure and vital signs.
Key players, such as CareSimple, Caretaker Medical, and SunTech Medical, Inc., are the major contributors to the market in the U.S. According to a recent survey, 75% of respondents who were given home blood pressure monitors plan to use them daily. The Centers for Disease Control and Prevention (CDC) reported that approximately 664,470 deaths were recorded in the U.S. related to high blood pressure.
The Canadian government makes constant efforts to increase awareness among healthcare professionals and patients about the management of hypertension. Hypertension Canada is a non-profit organization that deals with the prevention and management of hypertension and its complications in Canada. The organization generated a revenue of $34,625 in 2023 in the professional certification program, as well as $310,400 in 2023 in the device recommendation program.
Asia-Pacific is expected to grow at the fastest CAGR in the continuous blood pressure monitoring devices market during the forecast period. Hypertension is a major public health concern, especially among the elderly population, in the Asia-Pacific region. Government organizations launch initiatives to create awareness among the general public about early diagnosis and screening of cardiovascular disorders. The burgeoning medical device sector and the increasing number of startups contribute to market growth. The rising adoption of advanced technologies also facilitates the development of innovative continuous blood pressure monitoring devices.
The prevalence rate of hypertension among Chinese adults is estimated to be over 47% of the total population. As of June 2024, there were 32,700 medical device manufacturing enterprises in China. The Healthy China Initiative 2030 has set a target for hypertension prevention and control through regular blood pressure monitoring in adults aged 18 years and above.
The ICMR-INDIAB study reported an alarming rate of hypertension in India, affecting approximately 311 million people, or 30.7% of the total population. The Indian government’s Hypertension Control Initiative (HCI) (2021-2025) aims to reduce the prevalence of hypertension by 25% in India by 2025.
Research activities for continuous blood pressure monitoring devices refer to developing more accurate and portable wearable devices, leveraging advanced technologies.
Key Players: SunTech Medical, Caretaker Medical, and Omron Healthcare
Blood pressure monitoring devices undergo clinical trials for the assessment of safety and efficacy before marketing authorization. Regulatory agencies, such as the FDA, EMA, and NMPA, regulate the use of these devices.
Key Players: Aktiia Healthcare, Clario, and Lindus Health
Continuous blood pressure monitoring devices are distributed to hospitals, pharmacies, and drug stores. Numerous devices are sold without a prescription.
Skilled professionals provide extensive training to patients, guiding them about the use of innovative devices. Healthcare professionals analyze patients’ conditions and deliver tailored treatment.
Christoph Massner, Board Director at Aktiia, commented on FDA approval of its first cuffless blood pressure monitor, saying that the FDA clearance represents a breakthrough moment for medical-grade wearables. The team combined bold vision with scientific rigor. The Hilo Band is poised to lead a global transformation in understanding and managing cardiovascular health at scale.
By Device Type
By Technology
By Application
By End-User
By Region
September 2025
August 2025
July 2025
July 2025